JSAL

RLAY, too close for comfort, a long term RUN UP in play...

Long
NASDAQ:RLAY   Relay Therapeutics, Inc.
RLAY weekly chart is showing multiple support strength as proven by the triple bottom scenario. A significant net buying volume / accumulation has been spotted this past few weeks.

It has also created a notable higher lows on weekly data.

Average volume for the stock is at 1.4 M, but last trading day (apr. 13) the stock recorded 3.3M shares way above average conveying significant accumulation.

Expect a reversal from here on.

Seeded at 18.0

-----
Related news:

Relay Therapeutics
shares jumped over 13% in recent afternoon trading Thursday after Raymond James initiated coverage of the drugmaker's stock with an outperform rating and 29 price target.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.